Healthcare >> CEO Interviews >> November 8, 2001
LOTHAR KRINKE, is Vice President for Business Development and Strategic
Planning at Celera Genomics. Dr. Krinke is responsible for expanding and
developing the business strategy for Celera's Discovery and Online
Information businesses. He also focuses on mergers and acquisitions,
business development and strategic planning. Previously, Dr. Krinke was
at A.T. Kearney Inc., a global management consulting firm, where he was
Vice President in the Pharmaceutical practice, responsible for helping
biopharmaceutical companies develop R&D and marketing strategies. Prior
to that, he worked at McKinsey & Company, another leading management
consulting firm. Dr. Krinke serves on the Research Advisory Board and
co-chairs the Research Taskforce of the Juvenile Diabetes Research
foundation. Dr. Krinke obtained his undergraduate degree in Biology from
Technische Universitaet Braunschweig in Germany and his PhD in Molecular
Biology from the State University of New York at Albany. He also held an
American Cancer Society Postdoctoral Fellowship at the California
Institute of Technology. Profile
Celera Genomics Group?
Mr. Krinke: Celera was formed three years ago on the premise to sequence
the human genome, which
